Spero Therapeutics Aktie
1,63
EUR
-0,02
EUR
-1,09
%
1,97
USD
+0,01
USD
+0,51
%
Werbung
Spero Therapeutics Aktie Analyse
09.02.18 | Spero Therapeutics Overweight | Cantor Fitzgerald | |
27.11.17 | Spero Therapeutics Outperform | Oppenheimer & Co. Inc. | |
27.11.17 | Spero Therapeutics Buy | Stifel, Nicolaus & Co., Inc. |
Werbung
Werbung